How to Cite
Abstract
Total number of 648 endometrial cancer patients who had undergone hysterectomy, bilateral salpingo-ophorectomy and bilateral pelvic lymphadenectomy with laparoscopic and open access constituted the study group. Ultrasound examination of the pelvis was carried out for all patients after surgery to identify lymphocysts. The overall incidence of lymphocysts was 320/648 (49.4%): 179/320 (55.9%) after open surgery and 141/320 (44.06%) after laparoscopy (р=0,01). The majority of lymphocysts were asymptomatic. Symptomatic lymphocysts occurred in 5.6% of patients. Several risk factors for the development of symptomatic lymphocysts were determined.References
Берлев И.В., Некрасова Е.А., Урманчеева А.Ф. и др. Результаты лапароскопической хирургии рака эндометрия: опыт ФГБУ «НИИ онкологии им. Н.Н. Петрова»//Вопр. онкол. -2015. -Т 61. -№ 3. -С. 362 -368.
Берлев И.В., Ульрих Е.А., Некрасова Е.А. и др. Эндовидеохирургия (минимальная инвазивная хирургия) в лечении злокачественных опухолей женских половых органов: 5-летний опыт клиники ФГБУ «НИИ онкологии им. Н.Н. Петрова» Минздрава России//Вопр. онкол. -2016. -Т. 62. -№ 2. -С. 196 -207.
Бохман Я.В. Лимфатическое метастазирование при раке эндометрия//Вопр. онкол. -1962. -№ 8. -С. 98-107.
Бохман Я.В. Руководство по онкогинекологии. -Л.: Медицина, 1989. -464 с.
Каприн А.Д, Старинский В.В., Петрова Г.В. (ред.) Состояние онкологической помощи населению России в 2015 году//Москва. -2015. -С. 236.
Новикова Е.Г., Анпилогов С.В. Современный подход к хирургическому лечению рака эндометрия с применением лапароскопического доступа//Онкохирургия. -2014. -Т. 6. -№ 1. -С. 64-71.
Олейник В.В. Лимфатические кисты после расширенных операций по поводу рака шейки и тела матки//канд. дис. Онкология. -1996. -C. 25.
Charoenkwan K., Kietpeerakool C. Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for the prevention of lymphocyst formation in patients with gynaecological malignancies//Cochrane Database Syst Rev. -2014. -Issue 6.
Colomb N., Creutzberg C., Amant F. et. al. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up//Annals of Oncology. -2015. -P. 1-26.
Frost J.A., Webster K.E., Bryant A., Morrison J. Lymphadenectomy for the management of endometrial cancer//Cochrane Database Syst Rev. -2015. -Issue 9.
Kim H.Y, Kim J.W., Kim S.H. et al. An analysis of the risk factors andmanagement of lymphocele after pelvic lymphadenectomy in patients with gynecologic malignancies//Cancer Res. Treat. -2004. -V.36. P. 377-383.
Kitchener H., Swart A.M., Qian Q., et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study//Lancet. -2009. -Vol. 373. -P 125-136.
Mori N. Clinical and experimental studies on the so-called lymphocyst which evelops after radical hysterectomy in cancer of the uterine cervix//J. Jpn. Obstet. Gynecol. Soc. -1955. -Vol. 2. -P. 178-203.
Querleu D., Leblanc E., Cartron G. et al. Audit of preoperative and early complications of laparoscopic lymph node dissection in 1000 gynecologic cancer patients//Am. J. Obstet. Gynecol. -2006. -Vol. 195. -P 1287-1292.
Zikan M., Daniela F., Pinkavova I. et al. A prospective study examining the incidence of asymptomatic and symptomatic lymphoceles following lymphadenectomy in patients with gynecological cancer//Gynecol. Oncol. -2015. -Vol. 137. -P 291-298.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© АННМО «Вопросы онкологии», Copyright (c) 2017